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Scompared with the AbAchR-positive group. In contrast,
a significantly poorer improvement rate was observed in se-
ronegative patients. Some studies have found significantly
better clinical results in young patients with short disease
duration.5,21 The robotic procedure has an advantage of
being more easily and readily accepted by both
neurologists and young patients, because it produces good
cosmetic results and is less invasive. In our series, the
median duration of preoperative symptoms was 11
months, reflecting an early referral policy and rapid
acceptance. Despite no significant difference in CSR
based on age and symptom onset, a trend toward CSR
was observed in young patients with short (<1 year)
disease duration before surgery. Rates of detecting ectopic
thymic tissue are 22% to 39.5% in reported studies and
reached 26% in our experience. Some authors22 have high-
lighted the importance of ectopic thymic tissue in the main-
tenance of disease and have indicated that it is a negative
prognostic factor for remission. Our series of patients
with pathologic evidence of ectopic thymus tended to
have a lower probability for CSR.
CONCLUSIONS
Our study reports the outcome of a large group of patients
who underwent robotic thymectomy followed by a long
follow-up period. We demonstrated that robotic thymec-
tomy is a technically sound operation, with low morbidity
and short hospitalization. Neurologic long-term results
were good for both CSR and clinical improvement, with
a significant reduction in medication over time. In addition,
the optimal cosmetic results and minimal invasiveness of
this type of surgery were associated with its high acceptance
by both patients and neurologists, resulting in early referral
and potential further improvement in outcome. A close col-
laboration between thoracic surgeons and neurologists is
important in planning the best treatment strategy to achieve
optimal results.
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Dr Mithran Sukumar (Portland, Ore). You were succinct in
presenting your surgical results and neurologic outcomes after
thymectomy for myasthenia, particularly in the effect that it has
on the postoperative management of these patients. I have 2 ques-
tions for you.
The first is in regard to bleeding with robotic thymectomy.Would
you briefly discuss the possible sites and causes? Is there an inci-
dence of catastrophic bleeding, and how would you manage that?
Dr Marulli. All patients with postoperative bleeding did not
have a re-do operation, so we can suppose looking at the chest
x-ray that the bleeding was from one of the ports, probably in 2
cases from the port of the camera and in 2 cases from the port of
the parasternal area because these ports receive stress during ma-
neuvers and the parasternal port is the port that we use to remove
the specimen; thus, it may be damaged. There is no relationship
with the experience. Recently, we had another case of bleeding
in which we performed reoperation. The bleeding was from the
thoracic vessels, probably because the resident damaged therdiovascular Surgery c Volume 145, Number 3 735
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Svessels during the small opening of the access. There was no intra-
operative bleeding, but eventually its management could be diffi-
cult, probably requiring an open conversion.
Dr Sukumar. My second question is to deal with this whole
idea of robotic thymectomy. Your slide presented the possible ad-
vantages of robotic thymectomy, but would you discuss the real
disadvantages at this time?
DrMarulli. There are some disadvantages. Some are important
and some are less important. For example, one of the most com-
mon disadvantages is the absence of tactile feedback. This is not
an important disadvantage because superior vision is enough to
overcome this limitation. The main technical disadvantage is prob-
ably when you have bleeding from a large vessel. The necessity for
emergency conversion can be more difficult for 2 reasons. The first
reason is that the main surgeon is far from the patient and is not
scrubbed, so you should have an assistant who should be able to
do an emergency conversion. Moreover, the emergency conversion
can be difficult because the robot is over the patient, so you do not
have much space. On the other hand, the control of the vessel may
be better because of the high degree and complexity of the move-
ments allowed by robotic instruments, so you can grasp the vessel
to temporarily control the bleeding. Another limitation is the cost.
The fixed cost can be reduced by using the robot in amultidisciplin-
ary setting. In our hospital we use the robot with the urologist, gy-
necologist, and general surgeons. Although the cost of the
disposable materials is obviously high, it is not recoverable. An-
other limitation is the absence of suction devices, which can be
a limitation not only for the thymectomy, which is an easy tech-
nique with no need for suction, but also for the lobectomy.
Dr Joseph Shrager (Stanford, Calif). All the robotic talking
points that we commonly hear about are nice (eg, reduction of
tremor), and it is probably fun to do a thymectomy that way. But
we have published that transcervical thymectomy has almost no
cost, there is no fancy equipment, and we have a higher CSR
rate than you have published. You can also do it as an outpatient
procedure. There is essentially no pain for the patient and almost
no morbidity. The only bad thing about that procedure is that it
is hard to find places where people can learn how to do it. It is
hard to justify all the costs of robot—given the talks we have heard
during this whole meeting about economics—when you can do
this thymectomy quickly and with at least as good results with
nothing other than a little substernal retractor.
Dr Marulli. I agree with you. I know your work, and I think
transcervical thymectomy can become the standard of care in
this kind of patient. We need more reliable results because at the
time only a few articles address these types of results. Moreover,
I have 2 concerns. Although I never used the transcervical ap-
proach, my chief had a good experience with this approach, and
he considers the transcervical technique somewhat difficult to
learn in comparison with the robot technique, so my concern is
the learning curve. Moreover, your experience is the best experi-
ence. You have 8% open conversion if I remember, probably split
conversion, which is higher than the robotic technique. We have
0% conversion, so I do not know if the technique is ready to be736 The Journal of Thoracic and Cardiovascular Surgwidely used, but it absolutely is the best of mini-invasive tech-
niques in my opinion.
Dr Shrager. Almost all the conversions were in cases that I
would not now recommend the procedure be attempted, where
we were trying to do it for a small thymoma, and I would not rec-
ommend it for those cases. Also, you learn after a while that it can-
not be done if the patient cannot really extend his or her neck well.
It is not hard to learn; it is just that there are only a few places or
people who can teach you how to do it. I mean, the residents can do
it after basically seeing one of them. It is simple, and I would invite
anybody who wants to learn how to do it. Cases are not all that fre-
quent, but anyone who wants to learn could come to Stanford and
see how it is done.
Dr Marulli. I like the transcervical thymectomy. My experi-
ence in the robotic thymectomy was positive, and the learning
curve with robotic technique was easy.
Dr David Follette (Sacramento, Calif). I agree with Joe about
the transcervical thymectomy. Over the years at this meeting, we
have heard a number of talks. I have never seen a nicer one describ-
ing the robotic technique, but my comment and question is not can
you do it but should you do it? The whole field of robotic surgery
with few exceptions has never been proven to improve long-term
outcomes or mortality. It improves cosmetics; you do not get a ke-
loid. As we learned this morning, procedures that are fancy and
look great on the Internet may not really be justified unless there
are outcomes. Thoracic surgery has spent a lot of our time, espe-
cially in the world of oncology, trying to figure out what is best
for the patient before adopting new techniques. My concern is,
and my philosophy has evolved, if you have 2 techniques and
your patient is worried about cosmetics and wants to pay the extra
$35,000 out of pocket, so be it unless you really have evidence that
the long-term outcome, not just 1 day shorter in the hospital or
nicer scar, is better. Have you compared, because you have an ex-
tensive experience and a wonderful team, the actual long-term out-
come of standard techniques versus robotic techniques in terms of
certain patients who have recidivism of their myasthenia symp-
toms long-term and increased doses of medication. Have you
made an effort to look at the long-term outcomes, and can you hon-
estly say there is a distinct benefit to the patient that justifies the
significant increase in cost other than cosmesis? People in the
United States, if they want cosmetic surgery, they pay for it out
of their pockets.
Dr Marulli. I do not have a reply for this question because we
did not compare with the previous technique, and a retrospective
comparison is not useful, so we have to wait for major data from
studies adopting the MGFA classification, the same criteria. We
shifted from the classic conventional video-assisted thoraco-
scopic approach to the robotic approach. From a technical point
of view, there is a big difference. In our previous experience, we
had at least 30% of patients who required a further transcervical
approach and approximately 10% of patients required an open
conversion, so from a technical point of view, the resection is
safer, bigger, and more radical. For long-term results, I have
no reply for you.ery c March 2013
